IHL 0.00% 4.1¢ incannex healthcare limited

Ann: Positive Results from IHL-675A (ARDS) in vitro Study, page-63

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 124 Posts.
    lightbulb Created with Sketch. 126
    Absolute ripper result here,
    Correct me if I'm wrong but the fact that this was a complete success pretty much de-risks the whole trial doesn't it? The next animal study will be about finding optimal dosage leading into FDA emergency use approval, meaning that the hard yards have already been completed?
    My understanding would be that from here we have a very small chance of failure and an almost certain chance of success? Am I correct in assuming this?
    Thanks holders!
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.